2024 Rome, Italy

IV-76 Li Zhu
Population Pharmacokinetic Modeling of Ulocuplumab, an anti-CXCR4 Monoclonal Antibody in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Multiple Myeloma
Thursday 14:40-16:00